Un fármaco para el cáncer podría ser un potente tratamiento para la EM
JUEVES, 14 de julio de 2022 (HealthDay News) — Un medicamento que se usa “fuera de etiqueta” para la esclerosis múltiple (EM) es más efectivo que la medicación estándar para prevenir las exacerbaciones de los síntomas, encontró un nuevo ensayo clínic…
Learn MoreCancer Med Might Be Powerful Treatment for MS
THURSDAY, July 14, 2022 (HealthDay News) — A drug used “off-label” for multiple sclerosis (MS) is more effective than a standard medication at preventing symptom flare-ups, a new clinical trial has found.The drug, called rituximab, is approved in the…
Learn MorePrevalence of MS Similarly High in Black, White Individuals
THURSDAY, April 28, 2022 (HealthDay News) — The prevalence of multiple sclerosis (MS) is similarly high in Black and White individuals and is lower in Hispanics and Asians, according to a study published online April 27 in Neurology.Annette M. Langer…
Learn More